Clinico-genomic characterization of N=2,460 pancreatic adenocarcinoma identifies KRASMUT dosage as prognostic of overall survival across disease stagesAnna M. Varghese, Maria A. Perry, Daniel Muldoon,Subhiksha Nandakumar,Amanda Erakky,Bastien Nguyen, Amanda Zucker,Hulya Sahin Ozkan,Olca Basturk,Debyani Chakravarty,David P. Kelsen,Wungki Park,Kenneth H. Yu,Alice C. Wei,Nikolaus Schultz,Michael F. Berger,Christine Iacobuzio-Donahue,Chaitanya Bandlamudi, Eileen M. O'ReillyCANCER RESEARCH（2024）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
